NDC 13533-800 Gamunex-c

Immune Globulin (human) Injection Intravenous; Subcutaneous - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
13533-800
Proprietary Name:
Gamunex-c
Non-Proprietary Name: [1]
Immune Globulin (human)
Substance Name: [2]
Human Immunoglobulin G
NDC Directory Status:
Plasma Derivative
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s): [4]
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Labeler Name: [5]
    Grifols Usa, Llc
    Labeler Code:
    13533
    FDA Application Number: [6]
    BLA125046
    Marketing Category: [8]
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date: [9]
    10-13-2010
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Navigator:

    Product Characteristics

    Color(s):
    WHITE (C48325 - CLEAR TO OPALESCENT LIQUID, COLORLESS TO PALE YELLOW)

    Product Packages

    NDC Code 13533-800-12

    Package Description: 1 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS (13533-800-13)

    NDC Code 13533-800-15

    Package Description: 1 VIAL, GLASS in 1 CARTON / 25 mL in 1 VIAL, GLASS (13533-800-16)

    NDC Code 13533-800-20

    Package Description: 1 VIAL, GLASS in 1 CARTON / 50 mL in 1 VIAL, GLASS (13533-800-21)

    NDC Code 13533-800-24

    Package Description: 1 VIAL, GLASS in 1 CARTON / 200 mL in 1 VIAL, GLASS (13533-800-25)

    NDC Code 13533-800-40

    Package Description: 1 VIAL, GLASS in 1 CARTON / 400 mL in 1 VIAL, GLASS (13533-800-41)

    NDC Code 13533-800-71

    Package Description: 1 VIAL, GLASS in 1 CARTON / 100 mL in 1 VIAL, GLASS (13533-800-72)

    Product Details

    What is NDC 13533-800?

    The NDC code 13533-800 is assigned by the FDA to the product Gamunex-c which is a plasma derivative product labeled by Grifols Usa, Llc. The generic name of Gamunex-c is immune globulin (human). The product's dosage form is injection and is administered via intravenous; subcutaneous form. The product is distributed in 6 packages with assigned NDC codes 13533-800-12 1 vial, glass in 1 carton / 10 ml in 1 vial, glass (13533-800-13), 13533-800-15 1 vial, glass in 1 carton / 25 ml in 1 vial, glass (13533-800-16), 13533-800-20 1 vial, glass in 1 carton / 50 ml in 1 vial, glass (13533-800-21), 13533-800-24 1 vial, glass in 1 carton / 200 ml in 1 vial, glass (13533-800-25), 13533-800-40 1 vial, glass in 1 carton / 400 ml in 1 vial, glass (13533-800-41), 13533-800-71 1 vial, glass in 1 carton / 100 ml in 1 vial, glass (13533-800-72). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Gamunex-c?

    This medication is used in people with a certain type of weakened immune system (primary immune deficiency) to strengthen it and to lower the risk of infection. This medication is made from human blood that has a high level of antibodies which help fight infections. This product is also used to increase the number of certain blood cells (platelets) in people with a certain blood disorder (idiopathic thrombocytopenic purpura-ITP). Platelets are needed to stop bleeding and to form normal blood clots. In addition, this medication is used to treat a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). This disorder causes weakness and numbness/tingling/pain in the arms and legs. This medication helps to improve these symptoms and prevents relapse.

    What are Gamunex-c Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Gamunex-c UNII Codes?

    The UNII codes for the active ingredients in this product are:

    • HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS)
    • HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (Active Moiety)

    Which are Gamunex-c Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Gamunex-c?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    Which are the Pharmacologic Classes for Gamunex-c?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".